Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,551 | 277 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $822.96 | 73 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $704.38 | 32 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $642.79 | 28 | $0 (2024) |
| Neuronetics, Inc. | $582.98 | 6 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $550.99 | 21 | $0 (2024) |
| Alkermes, Inc. | $392.16 | 19 | $0 (2024) |
| Axsome Therapeutics, Inc. | $375.81 | 18 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $314.94 | 17 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $228.74 | 16 | $0 (2024) |
| ITI, Inc. | $223.56 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,865 | 69 | Neuronetics, Inc. ($582.98) |
| 2023 | $2,087 | 112 | Teva Pharmaceuticals USA, Inc. ($406.08) |
| 2022 | $974.24 | 60 | Janssen Pharmaceuticals, Inc ($179.52) |
| 2021 | $625.33 | 36 | Otsuka America Pharmaceutical, Inc. ($154.26) |
All Payment Transactions
277 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $116.79 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $11.99 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Neuroscience | ||||||
| 10/28/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/25/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $4.59 | General |
| Category: Neuroscience | ||||||
| 10/24/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: Neuroscience | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $14.89 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Central Nervous System | ||||||
| 10/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $19.77 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 09/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: PSYCHIATRY | ||||||
| 08/27/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Neuropsychiatry | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: PSYCHIATRY | ||||||
| 07/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $30.29 | General |
| Category: Psychology/Psychiatric | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 91 | 251 | $38,998 | $14,306 |
| 2022 | 3 | 92 | 261 | $41,118 | $15,256 |
| 2021 | 3 | 48 | 99 | $16,154 | $6,032 |
| 2020 | 2 | 23 | 46 | $6,757 | $2,199 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 116 | $18,834 | $7,417 | 39.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 35 | 115 | $14,561 | $4,573 | 31.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 20 | 20 | $5,603 | $2,316 | 41.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 127 | $20,620 | $8,271 | 40.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 34 | 111 | $14,055 | $4,629 | 32.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 23 | 23 | $6,443 | $2,356 | 36.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 20 | 54 | $8,767 | $3,352 | 38.2% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 17 | 34 | $4,305 | $1,352 | 31.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 11 | 11 | $3,082 | $1,328 | 43.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 25 | $4,034 | $1,282 | 31.8% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 12 | 21 | $2,723 | $916.87 | 33.7% |
About Michelle Head
Michelle Head is a Psychiatric/Mental Health healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2019. The National Provider Identifier (NPI) number assigned to this provider is 1568929826.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michelle Head has received a total of $5,551 in payments from pharmaceutical and medical device companies, with $1,865 received in 2024. These payments were reported across 277 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($5,551).
As a Medicare-enrolled provider, Head has provided services to 254 Medicare beneficiaries, totaling 657 services with total Medicare billing of $37,793. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Little Rock, AR
- Active Since 02/22/2019
- Last Updated 02/22/2019
- Taxonomy Code 363LP0808X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1568929826
Products in Payments
- VRAYLAR (Drug) $822.96
- REXULTI (Drug) $738.35
- NEUROSTAR TMS THERAPY SYSTEM (Device) $582.98
- SPRAVATO (Drug) $538.71
- Austedo XR (Drug) $379.12
- Auvelity (Drug) $359.85
- CAPLYTA (Drug) $336.68
- INGREZZA (Drug) $314.94
- ARISTADA (Drug) $232.96
- TRINTELLIX (Drug) $228.74
- INVEGA SUSTENNA (Drug) $165.67
- AUSTEDO (Drug) $156.98
- COBENFY (Drug) $143.67
- HETLIOZ (Drug) $103.02
- LYBALVI (Drug) $98.17
- Azstarys (Drug) $80.18
- ABILIFY ASIMTUFII (Drug) $53.46
- VIVITROL (Drug) $41.82
- AZSTARYS (Drug) $34.63
- Dyanavel XR (Drug) $20.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Little Rock
Cara Meckfessel, Aprn, APRN
Psychiatric/Mental Health — Payments: $7,199
Sara Jones, Phd, Aprn, Pmhnp-Bc, PHD, APRN, PMHNP-BC
Psychiatric/Mental Health — Payments: $4,663
Chloe Ward, Aprn, APRN
Psychiatric/Mental Health — Payments: $4,251
Jennifer Rawls, Aprn, APRN
Psychiatric/Mental Health — Payments: $3,031
Ashley Taylor, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $2,381
Kizzie Houston
Psychiatric/Mental Health — Payments: $2,250